Ledger.Open graph →
SEC Form D · Amendment · filed January 31, 2020

KOP Therapeutics Corp

Offering
$114K
Sold
$114K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ian H. Mann · VANCOUVER, British Columbia, CanadaDirectorTibor F. Gajdics · VANCOUVER, British Columbia, CanadaExec · DirectorMarco A. Strub · VANCOUVER, British Columbia, CanadaDirectorMark R. Redcliffe · VANCOUVER, British Columbia, CanadaExec · DirectorMark R. Redcliffe · VANCOUVER, British Columbia, CanadaExec · DirectorKate A. Kennedy · New York, NYExec · DirectorEvelyn A. Bagdasarova · New York, NYDirectorAnnielyn A. Gonzales · New York, NYDirectorBelinda Ridout · St Peter Port, Y7Exec · DirectorSam Hammons · Edmond, OKDirectorDan J. Bales · Edmond, OKDirectorW. J. Hughes · Edmond, OKExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗